Mass Spectrometric Measurements of 11-Deoxycortisol, Androstenedione and Dehydroepiandrosterone Are Superior to Cortisol to Assess Selectivity of Non-Stimulated Adrenal Vein Sampling.

IF 2.4 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Francesco Alessi, Christina Pamporaki, Mirko Peitzsch, Georgiana Constantinescu, Hanna Remde, Lydia Kürzinger, Carmina T Fuss, Manuel Schulze, Sybille Fuld, Sradha Kotwal, Jun Yang, Martin Reincke, Felix Beuschlein, Jacques W M Lenders, Graeme Eisenhofer
{"title":"Mass Spectrometric Measurements of 11-Deoxycortisol, Androstenedione and Dehydroepiandrosterone Are Superior to Cortisol to Assess Selectivity of Non-Stimulated Adrenal Vein Sampling.","authors":"Francesco Alessi, Christina Pamporaki, Mirko Peitzsch, Georgiana Constantinescu, Hanna Remde, Lydia Kürzinger, Carmina T Fuss, Manuel Schulze, Sybille Fuld, Sradha Kotwal, Jun Yang, Martin Reincke, Felix Beuschlein, Jacques W M Lenders, Graeme Eisenhofer","doi":"10.1111/cen.70037","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Successful adrenal venous sampling (AVS) is traditionally assessed using the ratio of cortisol in adrenal to peripheral venous plasma to calculate the selectivity index. With mass spectrometry other steroids can be simultaneously measured that may improve numbers of apparent successful sampling procedures.</p><p><strong>Design: </strong>Cross-sectional multicenter study.</p><p><strong>Patients: </strong>The study involved 229 patients who underwent unstimulated AVS for subtyping primary aldosteronism.</p><p><strong>Measurements: </strong>Adrenal and peripheral venous plasma cortisol, 11-deoxycortisol, androstenedione and dehydroepiandrosterone were measured by mass spectrometry to assess AVS selectivity. Ratios of aldosterone, measured by mass spectrometry, to each of the four steroids in right versus left adrenal venous plasma were used to assess lateralisation.</p><p><strong>Results: </strong>Selectivity indices for 11-deoxycortisol, androstenedione and dehydroepiandrosterone were respectively 5.7-(CI 5.1-6.2), 5.1-(CI 4.8-5.4) and 5.9-(CI 5.5-6.4) fold higher (p < 0.0001) than for cortisol. At selectivity index cut-offs of ≥ 3 and ≥ 2, rates of bilateral successful AVS were respectively 91% and 93% for 11-deoxycortisol, 90% and 91% for androstenedione and 89% and 91% for dehydroepiandrosterone, all higher (p < 0.0001) than the 69% and 85% respective success rates for cortisol. With 11-deoxycortisol, rates of apparent unsuccessful AVS procedures were reduced by 54%-72% compared to use of cortisol. There were no clear advantages of any single steroid over the others to assess lateralized aldosterone secretion.</p><p><strong>Conclusions: </strong>11-Deoxycortisol, androstenedione and dehydroepiandrosterone are more suitable biomarkers than cortisol to assess AVS selectivity and allow rescue of many procedures otherwise deemed unsuccessful. Measurements of cortisol to assess AVS selectivity are best replaced by mass spectrometric measurements of other steroids.</p>","PeriodicalId":10346,"journal":{"name":"Clinical Endocrinology","volume":" ","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Endocrinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/cen.70037","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Successful adrenal venous sampling (AVS) is traditionally assessed using the ratio of cortisol in adrenal to peripheral venous plasma to calculate the selectivity index. With mass spectrometry other steroids can be simultaneously measured that may improve numbers of apparent successful sampling procedures.

Design: Cross-sectional multicenter study.

Patients: The study involved 229 patients who underwent unstimulated AVS for subtyping primary aldosteronism.

Measurements: Adrenal and peripheral venous plasma cortisol, 11-deoxycortisol, androstenedione and dehydroepiandrosterone were measured by mass spectrometry to assess AVS selectivity. Ratios of aldosterone, measured by mass spectrometry, to each of the four steroids in right versus left adrenal venous plasma were used to assess lateralisation.

Results: Selectivity indices for 11-deoxycortisol, androstenedione and dehydroepiandrosterone were respectively 5.7-(CI 5.1-6.2), 5.1-(CI 4.8-5.4) and 5.9-(CI 5.5-6.4) fold higher (p < 0.0001) than for cortisol. At selectivity index cut-offs of ≥ 3 and ≥ 2, rates of bilateral successful AVS were respectively 91% and 93% for 11-deoxycortisol, 90% and 91% for androstenedione and 89% and 91% for dehydroepiandrosterone, all higher (p < 0.0001) than the 69% and 85% respective success rates for cortisol. With 11-deoxycortisol, rates of apparent unsuccessful AVS procedures were reduced by 54%-72% compared to use of cortisol. There were no clear advantages of any single steroid over the others to assess lateralized aldosterone secretion.

Conclusions: 11-Deoxycortisol, androstenedione and dehydroepiandrosterone are more suitable biomarkers than cortisol to assess AVS selectivity and allow rescue of many procedures otherwise deemed unsuccessful. Measurements of cortisol to assess AVS selectivity are best replaced by mass spectrometric measurements of other steroids.

质谱测量11-脱氧皮质醇、雄烯二酮和脱氢表雄酮优于皮质醇,以评估非刺激肾上腺静脉取样的选择性。
目的:肾上腺静脉取样(AVS)成功与否的传统评价是采用肾上腺皮质与外周静脉血浆中皮质醇的比值来计算选择指数。使用质谱法可以同时测量其他类固醇,这可能会增加明显成功采样程序的数量。设计:横断面多中心研究。患者:该研究涉及229例因原发性醛固酮增多症分型而接受无刺激AVS治疗的患者。测量方法:采用质谱法测定肾上腺和外周静脉血浆皮质醇、11-脱氧皮质醇、雄烯二酮和脱氢表雄酮,以评估AVS的选择性。用质谱法测量左、右肾上腺静脉血浆中醛固酮与四种类固醇的比值,以评估偏侧性。结果:11-去氧皮质醇、雄烯二酮和脱氢表雄酮的选择性指数分别高出5.7-(CI 5.1-6.2)、5.1-(CI 4.8-5.4)和5.9-(CI 5.5-6.4)倍(p)。结论:11-去氧皮质醇、雄烯二酮和脱氢表雄酮是比皮质醇更适合评估AVS选择性的生物标志物,并允许挽救许多被认为不成功的手术。评估AVS选择性的皮质醇测量最好由其他类固醇的质谱测量代替。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Endocrinology
Clinical Endocrinology 医学-内分泌学与代谢
CiteScore
6.40
自引率
3.10%
发文量
192
审稿时长
1 months
期刊介绍: Clinical Endocrinology publishes papers and reviews which focus on the clinical aspects of endocrinology, including the clinical application of molecular endocrinology. It does not publish papers relating directly to diabetes care and clinical management. It features reviews, original papers, commentaries, correspondence and Clinical Questions. Clinical Endocrinology is essential reading not only for those engaged in endocrinological research but also for those involved primarily in clinical practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信